EcoDrugPlus

Prostaglandin E Receptor 4

Ensembl ID : ENSUAMG00000008281
Gene Symbol: PTGER4
2 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSUAMG00000005141
Gene Symbol: PTGFR
2 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSUAMG00000016918
Gene Symbol: PTGIR
2 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSUAMG00000018256
Gene Symbol: PTGS1
2 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSUAMG00000015271
Gene Symbol: PTGS2
2 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSUAMG00000019824
Gene Symbol: PSMA1
2 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSUAMG00000025884
Gene Symbol: PSMA2
1 Cross references
188 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSUAMG00000007702
Gene Symbol: PSMA3
2 Cross references
235 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSUAMG00000017906
Gene Symbol: PSMA4
2 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSUAMG00000023474
Gene Symbol: PSMA6
2 Cross references
272 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSUAMG00000025273
Gene Symbol: PSMA7
2 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSUAMG00000003363
Gene Symbol: PSMB1
2 Cross references
213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).